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Accessory genesWe have previously described an in vitro primary thymocyte model for HIV latency that recapitulates several
important aspects of latently infected cells obtained from patients. Our original model included a truncated
HIV genome expressing only Tat, Rev, and Vpu along with a reporter gene. We have now expanded these
studies to include reporter viruses encoding more complete viral genomes. We show here that regions of the
viral genome outside of the long terminal repeat promoter and Tat/Rev regulatory genes can substantially
affect both the basal level of HIV transcription prior to stimulation, and also the level of viral expression
following costimulation via CD3 and CD28 ligation. These differences in latency phenotype between truncated
and more complete HIV genomes demonstrate the importance of accessory genes in the context of HIV
latency and indicate that care should be taken when interpreting data derived from heavily modiﬁed HIV
genomes in latency models., Division of Hematology and
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The ability of human immunodeﬁciency virus (HIV) to establish
and re-emerge from a latent state in CD4+ T cells is an important
barrier to eradication of the virus from infected individuals (Chun
et al., 1997; Finzi et al., 1999; Wong et al., 1997). Understanding the
molecular basis for HIV latency and the contribution of viral and host
factors in this process is therefore a signiﬁcant and pressing challenge.
However, the infrequent nature of latently infected cells obtained
from patients together with various difﬁculties inherent to their
analysis has necessitated the use of model systems that allow a more
thorough investigation of HIV latency (reviewed in (Han et al., 2007;
Marsden and Zack, 2009, 2010)). These have included various cell-
line-based approaches (Folks et al., 1987, 1989; Jordan et al., 2003),
andmore recently developed in vitro primary cell models (Bosque and
Planelles, 2009; Sahu et al., 2006). Our group has also been involved in
the development of ex vivo and in vitro primary cell models for HIV
latency, with the goal of better understanding how HIV enters into
latency and developing improved methods for activation and
elimination of latently infected cells (Arlen et al., 2006; Brooks andZack, 2002; Brooks et al., 2001, 2003a, 2003b; Burke et al., 2007; Korin
et al., 2002; Scripture-Adams et al., 2002).
One mechanism by which HIV can establish a latent infection in
T cells is during the process of thymopoiesis (Brooks et al., 2001). This
can occur because immature CD4+CD8+ thymocytes are metaboli-
cally and transcriptionally active enough to support a productive
infection by HIV. However, as these cells differentiate into naive
resting T cells they also become incapable of maintaining efﬁcient HIV
expression. Hence, if a thymocyte is infected at the CD4+CD8+ stage
of development then it can differentiate into a naïve T cell harboring a
latent provirus. We have previously utilized the SCID-hu thymus/liver
(Thy/Liv) mouse model (McCune et al., 1988; Namikawa et al., 1990)
to investigate the process of thymocyte infection by HIV, and to study
the molecular mechanisms associated with the establishment and
reactivation of latency in this cell type (Brooks et al., 2001). Thismodel
has proved useful for a range of applications including characterizing
the surface phenotypeof latently infected cells, identifying stimulatory
pathways that are capable of activating latent proviruses, and testing
methods for selectively eliminating these cells (Brooks and Zack, 2002;
Brooks et al., 2003a, 2003b; Korin et al., 2002). However the SCID-hu
model is also extremely labor-intensive and involves some other
limitations that can restrict its utility. For example, the requirement for
active virus replication in the SCID-hu model complicates direct
comparison of viruses harboring debilitatingmutations, such aswithin
the viral long terminal repeat (LTR) promoter.
To circumvent these issues, we developed an in vitro thymocyte
model based on similar principles to the SCID-hu latencymodel. In this
in vitromodel, puriﬁed CD4+CD8+ fetal thymocytes are infectedwith
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costimulation by ligation of CD3 and CD28 (Burke et al., 2007). This
procedure typically results in N100-fold induction of reporter
expression, and when used in conjunction with LTR mutants, was
used to demonstrate that the presence of NFκB binding siteswithin the
LTR is critical for maximal stimulation of virus expression (Burke et al.,
2007). Because this systemwas initially established to characterize the
LTR, we utilized a reporter virus that expressed only Tat, Rev, and Vpu
in conjunction with a reporter gene. We have now extended these
studies to include viruses withmore complete viral genomes. Here we
report that the expression proﬁle of HIV in both cytokine-treated and
costimulated thymocytes can be substantially affected by regions
outside of the viral promoter and regulatory genes. Remarkably, these
differences can inﬂuence virus expression sufﬁciently to dictate
whether HIV enters a latent or productive state in thymocyte cells.
Results
Viral activation assay
We previously described an in vitro HIV latency model in which
CD4+CD8+ double-positive fetal thymocytes were infected with an
HIV-based vector then differentiated into single-positive cells before
activation (Burke et al., 2007). To determine whether unsortedFig. 1. Viral activation assay using sorted CD4+CD8+ thymocytes and unsorted total thymoc
or after immunomagnetic enrichment of CD4+CD8+ cells. A) Cells were stained for CD4 and
isolation procedure typically resulted in a N99% purity of CD4+CD8+ cells. B) CD4+CD8+ c
7 post-infection cells were either left unstimulated, activated with anti-CD3 antibody alone,
then lysed and assayed for luciferase activity at day 10 post-infection. C) Total thymocytesthymocytes (aswould be present in vivo) produce a similar phenotype,
we isolated both total thymocytes and CD4+CD8+ double-positive
thymocytes from the same donor tissue. This procedure typically
resulted in a N99% pure population of CD4+CD8+ cells (Fig. 1A). The
cells were infected with NLEGFPLUC virus and then differentiated in
the presence of IL-2 and IL-4 for 1 week before stimulation with either
anti-CD3 antibody alone, or costimulation with anti-CD3 and anti-
CD28 antibodies. As previously described (Burke et al., 2007),
unstimulated CD4+CD8+ thymocytes expressed little or no reporter
activitywithout stimulation, but this activity increased N100-fold after
costimulation (Fig. 1B). In the current studywe found that stimulation
with anti-CD3 antibody alone was also sufﬁcient to activate virus, but
to a lesser extent than costimulation (Fig. 1B). When the same
procedure was performed with total thymocytes a similar pattern of
activitywas evident, althoughwith uniformly higher levels of reporter
expression (Fig. 1C). This is likely due to the enhanced viability of total
thymocytes, which are composed of a more physiological mix of cells
that have not been subjected to the same sorting procedures as the
puriﬁed double-positive cells.
Comparison of NLEGFPLUC with more complete HIV genomes
The apparently latent phenotype obtained after infection of either
unsorted or sorted thymocytes with NLEGFPLUC is striking, becauseytes. Total thymocytes were isolated from fetal thymic tissue and infected either directly
CD8 surface markers both pre- and post-sort and then analyzed by ﬂow cytometry. This
ells were infected with NLEGFPLUC then cultured for 1 week prior to stimulation. At day
or activated by costimulation using both anti-CD3 and anti-CD28 antibodies. Cells were
were infected with NLEGFPLUC and assayed as described in part B.
396 M.D. Marsden et al. / Virology 417 (2011) 394–399productive infection of thymocyte cells with replication-competent
HIV is common. Indeed, when HIV NL4-3 is added to thymocyte
cultures under similar conditions it spreads readily (Fig. 2A)
(Uittenbogaart et al., 1994). It was possible that the unusual
phenotype was somehow related to the VSV-pseudotyping of
NLEGFPLUC, or to the limitation of this virus to a single-round of
infection. Therefore we compared total thymocyte infections per-
formed in parallel with either NLEGFPLUC or denv(Wt) (Marsden and
Zack, 2007). This latter reporter virus is also VSV-pseudotyped but is
produced from a more complete HIV genome clone that expresses a
protein consisting of EGFP fused to luciferase in place of env, but
retains expression of all other HIV genes (Fig. 2B). Over the ﬁrst 2 days
of total thymocyte infection with these viruses NLEGFPLUC was
indistinguishable from mock. In contrast, denv(Wt) displayed sub-
stantial gene expression (Fig. 2C). Therefore some component of the
denv(Wt) virus that is absent from NLEGFPLUC is responsible for
severely altering the infection characteristics of these two viruses in a
manner inﬂuenced by the stimulation level of the host cell.
Complete timecourses +/− Nef
In order to assess the potential contribution of Nef to the observed
phenotype in thymocyte cells, a nef-frameshifted version of denv(Wt)
termed denv(NEF-FS) was constructed. The viruses were titered
in parallel in CEM cells using a limiting dilution procedure, andFig. 2. Replication and expression kinetics in primary thymocytes. A) Fetal thymocytes were
the presence of IL-2 and IL-4, (without costimulation) and monitored by ELISA for HIV
rapidly in thymocyte culture. B) Schematic diagram of the NLEGFPLUC and denv(Wt) HIV v
thymocytes were infected with either NLEGFPLUC or denv(Wt), and cells were assayed f
containing IL-2 and IL-4 without costimulation.equivalent infectious units used to infect thymocytes at a multiplicity
of infection of approximately 0.05. CD4+CD8+ thymocytes were
isolated and infected with NLEGFPLUC, denv(Wt), or denv(NEF-FS)
viruses and 200,000 viable cells were taken from the cultures each day
for luciferase analysis. Cells were incubated for 7 days in the presence
of IL-2 and IL-4 and then costimulated with anti-CD3 and anti-CD28
antibodies for a further 3 days. Results for NLEGFPLUC were similar to
those obtained previously, where the virus only expressed after the
cells were costimulated (Fig. 3, left panel). In contrast denv(Wt)
consistently expressed both prior to and after costimulation. Reporter
expression in denv(Wt) infected cells also increased following
costimulation but to a much lesser extent than with NLEGFPLUC
(Fig. 3, center panel). Disrupting the Nef coding sequence within denv
(Wt) did not prevent background expression of the virus, and in fact
the background expression of the denv(Nef-FS) virus was increased
slightly with respect to the parental virus (Fig. 3, right panel).
However, the overall kinetic of the denv(NEF-FS) virus in this assay
was more similar to denv(Wt) than to NLEGFPLUC. Therefore the
absence of Nef in NLEGFPLUC proviruses was not the reason for its
lack of expression in thymocytes without overt costimulation.
The potential contribution of Vpr to the thymocyte phenotype was
then assessed by constructing two new viruses. In the ﬁrst virus Vpr
was added back to the NLEGFPLUC virion by using a packaging
construct that encodes Vpr. In the second virus a Vpr-frameshift
mutation was introduced into denv(Wt), producing both virions andisolated and infected with replication competent HIV (NL4-3). Cells were incubated in
p24 protein accumulation in the supernatant. Under these conditions HIV spreads
ectors. denv(Wt) contains a GFP–luciferase reporter gene in place of HIV env. C) Total
or luciferase activity at days 0, 1, and 2 post-infection. Cells were cultured in media
Fig. 3. Timecourse in CD4+CD8+ thymocytes. CD4+CD8+ thymocytes were infected with equivalent infectious units of either NLEGFPLUC, denv(Wt), or denv(NEF-FS). At 7 days
post-infection cells were divided into costimulated or unstimulated conditions (indicated with arrow). Quadruplicate samples of 200,000 viable cells were harvested at each
timepoint and assayed for luciferase activity. For clarity, results for each virus are shown on a separate panel with the same mock control values.
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infect CD4+CD8+ thymocytes and samples were taken immediately
post-infection and again at d6 post-infection. Addition of vpr to the
NLEGFPLUC virus and removal from denv(Wt) did not alter their
expression characteristics with respect to the parental viruses (Fig. 4).
Therefore Vpr was not responsible for the increased basal expression
levels in these cells.
Discussion
In addition to directly contributing to HIV pathogenesis, infection
of thymocyte cells by HIV can also inﬂuence viral persistence by
providing a mechanism for the establishment of latency (Brooks et al.,
2001). In the current work we have expanded our investigation of this
postintegration latency in thymocytes. We previously demonstrated
that in vitro infection of cytokine-stimulated CD4+CD8+ thymocytes
with a truncated HIV-based reporter virus (NLEGFPLUC) produces
cells harboring an integrated, but tightly latent, provirus (Burke et al.,
2007). These cells express little or no reporter activity over the course
of a 10 day assay period unless the cells are ﬁrst allowed to
differentiate for several days and are then costimulated with anti-
CD3 and anti-CD28 antibodies. Here we show that this pattern of
activity is emulated in total thymocyte cell cultures that have been
treated in the same manner (Fig. 1). However, when replication-
competent HIV is used in this procedure, a productive infection
ensues. Moreover, a reporter virus that is Env-deﬁcient but encodes
all other HIV genes (denv[Wt]) is also capable of expressing in total
thymocytes without costimulation (Fig. 2). When performing aFig. 4. Reporter expression in thymocytes after infection with virions +/− Vpr.
Thymocytes were infected with virions either containing or deﬁcient in Vpr protein.
These cells were assayed both immediately post-infection and at day 6 post-infection.complete 10-day timecourse experiment, in which the cells are
costimulated for the ﬁnal 3 days of the assay, the expression proﬁles
of NLEGFPLUC and denv(Wt) are quite distinct. NLEGFPLUC expresses
at a much lower level prior to stimulation and a consistently higher
level after stimulation than denv(Wt) (Fig. 3). These observations
indicate that the establishment of a latent or productive infection in
thymocyte cells can be strongly inﬂuenced by factors outside of the
LTR promoter and Tat/Rev regulatory loops.
Several potential mechanisms could underlie the differences in
expression proﬁle between NLEGFPLUC and more complete viral
genomes. One possibility is that differing virion compositions could
inﬂuence virus expression in thymocytes. In particular, the NLEGF-
PLUC virions were originally produced using the vpr-deﬁcient
packaging construct pCMVΔR8.2DVPR (An et al., 1999; Naldini et al.,
1996), resulting in virions that do not contain the Vpr protein. Vpr has
been shown to be important for infection of some primary cell types
(Connor et al., 1995). We therefore produced NLEGFPLUC virions with
a packaging construct that contains vpr. A vpr-deﬁcient version of
denv(Wt) was also constructed and included for comparison. The
addition of Vpr to NLEGFPLUC or removal of Vpr from denv(Wt) did
not alter the expression proﬁles of these viruses in thymocytes
(Fig. 4), illustrating that Vpr was not the source of the different virus
characteristics. A second possibility is that de novo expression of an
HIV accessory/regulatory protein by the denv(Wt) provirus in the
newly infected target cell enhanced expression sufﬁciently to allow
detectable reporter activity. This is unlikely to be due to differences in
expression of Tat, Rev, or Vpu because these genes are encoded by the
packaged RNA in both viruses, and therefore they would be present
and expressed by each provirus in the newly infected thymocyte cells.
Vif was also present in both NLEGFPLUC and denv(Wt) virions, and
because this viral protein functions primarily in a producer-cell-
dependent fashion (Sheehy et al., 2002), or prior to integration in a
newly infected host cell (Chiu et al., 2005), it is unlikely to modulate
viral gene expression in themanner observed here. In contrast, the nef
open reading frame is not functional in the NLEGFPLUC provirus. Nef
has been shown to be capable of interacting with cellular kinases and
modulating the state of the cell in multiple ways that enhance viral
expression (Baur et al., 1997; Renkema et al., 2001; Simmons et al.,
2001). To determine whether Nef is the factor that allows expression
of denv(Wt) in thymocytes prior to costimulation, we introduced an
inactivating mutation into the nef open reading frame of denv(Wt) to
produce denv(NEF-FS). This virus was similar in function to that of the
denv(Wt) (Fig. 4), demonstrating that Nef only modestly inﬂuences
expression in this system, and the lack of Nef in NLEGFPLUC is unlikely
to explain its latent phenotype in cytokine stimulated thymocytes.
It therefore appears that the difference in phenotype may be a
product of multiple viral accessory proteins acting in concert, internal
398 M.D. Marsden et al. / Virology 417 (2011) 394–399enhancer elements (Van Lint et al., 1994), or a more complex
interaction involving other components of the viral genome such as
splice sites.
Conclusion
Our data show that infection of primary thymocytes with a
truncated HIV-based vector leads to markedly different expression
proﬁles than occurs during wild-type HIV infection, or during
infections using vectors based on more complete viral genomes. The
mechanism for establishment of latency using NLEGFPLUC is different
than in cell linemodels such asU1 (Folks et al., 1987) andACH-2 (Folks
et al., 1989), which are latent primarily because of mutations in Tat or
the trans-activator response region (TAR) respectively (Emiliani et al.,
1996, 1998). This indicates that the observed differences in post-
integration latency in thymocytes are due to factors outside of the LTR
and Tat/Rev regulatory protein coding sequences. One important
feature of these results relates to the more general use of HIV vectors
in latency experiments. Latencymodels utilizing truncated orminimal
HIV genomes have produced valuable information as experimental
systems (Kim et al., 2006; Weinberger et al., 2005). However our data
suggest that latency using certain truncated reporter viruses may not
accurately reﬂect the phenotype obtained using complete virus. Thus
one must take care not to over-interpret these types of system.
Methods
Molecular cloning and plasmid construction
NLEGFPLUC was originally constructed by replacing the enhanced
green ﬂuorescent protein (EGFP) sequence in DAEGFP (An et al.,
1999) with an EGFP–luciferase (EGFPLuc) fusion protein as previously
described (Burke et al., 2007). This plasmid contains a truncated HIV-1
genome that encodes only Tat, Rev, and Vpu in addition to the EGFPLuc
reporter gene. denv(Wt) encodes the EGFPLuc reporter gene in place
of Env, but expresses all other HIV genes (Marsden and Zack, 2007).
The nef-frameshifted mutant denv(NEF-FS) was constructed by ﬁrst
performing a partial digest of denv(Wt) to cleave the Xho I restriction
site within the nef open reading frame. The product of this digest was
then used in an end-ﬁlling reaction using T4 DNA polymerase,
followed by ligation of the resultant blunt-end DNA fragment. denv
(VPR-FS) was created by partial digest of denv(Wt) to cleave only the
EcoRI sitewithin Vpr, followed by a T4DNApolymerase catalyzed end-
ﬁlling reaction and ligation. All plasmids were expanded in the Stbl3
strain of Escherichia coli (Invitrogen).
Virus production
Viruses pseudotyped with vesicular stomatitis virus G (VSV-G)
protein were generated by transfection of 293FT cells using
Lipofectamine 2000 reagent (Invitrogen). The day before transfection
cells were seeded at a concentration of 6.6×106 cells/well in 10 cm
dishes. To generate denv(Wt), denv(NEF-FS), and denv(VPR-FS)
viruses, each plate was cotransfected with 10 μg of the relevant
virus-encoding plasmid and 2 μg of pHCMVG. For generation of
NLEGFPLUC virus, 5 μg of NLEGFPLUC, 2 μg of pHCMVG, and 5 μg
of either pCMVΔR8.2DVPR (An et al., 1999; Naldini et al., 1996) (for
Vpr− virions) or pCMVΔR8.2 (Naldini et al., 1996) (for Vpr+ virions)
were added per plate. The cells were incubated for 20 hours with
Lipofectamine/DNA complexes then incubated for a further 30 hours
with fresh media before virus harvesting. After this incubation, the
media was recovered and centrifuged at 800g for 5 minutes to remove
any ﬂoating cells. The supernatant was then ﬁltered (0.45 μm) and
the virus was concentrated by ultracentrifugation at 50,000g for
90 minutes at 4 °C. Aliquots were stored, frozen at−80 °C and thawed
immediately before use. HIV p24 protein concentration was assayedusing an HIV p24 antigen ELISA kit (Beckman Coulter) according to
manufacturer's instructions. Viral titrations were performed by
infection of 293FT cells as previously described (Burke et al., 2007).
Cell culture and isolation procedures
All cells were cultured in 5% CO2 at 37 °C and cell lines were split
every 2–3 days as needed. 293FT cells were cultured in Dulbecco's
modiﬁed Eagle medium (Invitrogen) containing 10% fetal bovine
serum (FBS, Omega Scientiﬁc), 100 μg/ml of G418 (Invitrogen), and
100 units/ml of penicillin+100 μg/ml of streptomycin (Pen/Strep,
Invitrogen). Primary thymocytes were cultured in thymocyte culture
media composed of Iscove's modiﬁed Dulbecco's medium (IMDM,
Irvine Scientiﬁc) supplemented with 10% human AB serum (Sigma),
4 mM L-glutamine (Invitrogen), Pen/Strep, 20 units/ml of interleukin
(IL)-2 (Roche), and 20 ng/ml of IL-4 (Invitrogen).
All cell sorting was performed by using immunomagnetic beads
and an autoMACS cell sorter (Miltenyi Biotec) according to the
manufacturer's instructions. Fetal thymic tissues of 18 to 24 weeks
gestational age were obtained from Advanced Bioscience Resources
with appropriate Institutional Review Board permission. Total
thymocytes were extracted by suspending thymic tissue in IMDM
containing 10% FBS, 4 mM L-glutamine, and Pen/Strep, shredding it
through a stainless steel screen, and then passing the resultant cell
suspension through a 40 μm ﬁlter. For isolation of CD4+CD8+
thymocytes, CD8+ cells were ﬁrst isolated by positive selection
using a human CD8 MultiSort kit. The magnetic beads were then
removed and the CD4+CD8+ (double positive) cells were isolated by
positive selection using human CD4 MicroBeads. During costimula-
tion, cells were activated for 3 days using plate-bound anti-CD3 and
soluble anti-CD28 antibodies as previously described (Brooks et al.,
2001; Burke et al., 2007).
Flow cytometry
Cells were stained for surfacemarker expression usingmouse anti-
CD4 phyco-erythrin, and CD8 peridinin-chlorophyll protein complex
antibodies (Beckman Coulter). Data were acquired using a FACSCa-
libur (Becton Dickinson) ﬂow cytometer and analyzed with FlowJo
(v7) software.
Luciferase assays
Expression of ﬁreﬂy luciferase was quantiﬁed using the Luciferase
Assay System (Promega) according to the manufacturer's instructions.
Cells were washed with 1× phosphate buffered saline, pelleted,
resuspended in 100 μl of 1× cell lysis buffer, vortexed brieﬂy, and then
stored at −80 °C. During analysis, cells were thawed and mixed with
100 μl of luciferase assay reagent. Lysates were analyzed using a
Monolight 2010 (Analytical Luminescence Laboratories), a FLUOstar
OPTIMA (BMG LABTECH), or a Lmax luminometer (Molecular Devices).
Infection procedures
All infections were performed by incubating cells at 37 °C for
2 hours with virus in media containing 10 μg/ml of polybrene.
Thymocytes were infected in a total volume of 1 ml, and after
infections cells were washed and resuspended in 1 ml of thymocyte
culture media at a concentration of between 2×106 cells/ml and
2×107 cells/ml in round-bottomed tissue culture tubes. For cells
infected with reporter viruses, aliquots of 200,000 viable cells were
removed at various times post-infection and processed in a luciferase
assay. Infection of thymocytes with replication-competent virus was
performed as above using 100 ng of HIV NL4-3 and 2×107 thymocyte
cells. Aliquots of cell-free supernatant were then removed from the
cultures at various times and assayed using an ELISA assay.
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